In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Renato Lopes
Speaker
Renato Lopes
Renato Lopes Renato Lopes

Duke University Medical Center, Durham (United States of America)

Specialities : Acute Coronary Syndromes , Acute Cardiac Care

Renato D. Lopes, MD, MHS, PhD is a Professor of Medicine of the Department of Medicine of the Division of Cardiology at Duke University Medical Center, in Durham, North Carolina, USA. He completed his clinical training at the Federal University of Sao Paulo, Sao Paulo, Brazil and his Cardiology Fellowship at the Duke Clinical Research Institute (DCRI), serving as Chief Fellow for the research training program during his senior year. He is currently the Director of Clinical Events Classification (CEC) and the Co-Director of the Integrated Clinical Events-Safety Surveillance Group at the DCRI. Dr. Lopes has an interest in novel antithrombotic therapies for the management of patients with atrial fibrillation and acute coronary syndromes as well as in the discovery of new biomarkers in the field of Cardiology. Dr. Lopes has led several national and international clinical trials and registries. He has also participated in clinical events committees (CECs) for many important clinical trial

11 presentations from this speaker

AF patients with ACS: recent insights from AUGUSTUS and other trials.

Event : EHRA 2019

  • Session : Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS)
  • Speaker : R Lopes (Durham,US)
  • Sponsored by BMS/Pfizer Alliance

Discussant review - ENTRUST-AF-PCI

Event : ESC Congress 2019

  • Session : Hot Line Session 6
  • Speaker : R Lopes (Durham,US)

Exploring evidence for long-standing questions

Event : ESC Congress 2019

  • Session : Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)
  • Speaker : R Lopes (Durham,US)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Exploring outstanding unmet needs in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention

Event : ESC Congress 2019

  • Session : Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation
  • Speaker : R Lopes (Durham,US)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Optimising NOAC management in atrial fibrilllation and ACS/PCI - Clinical practice perspective

Event : ESC Congress 2019

  • Session : Optimising non-vitamin K antagonist oral anticoagulant (NOAC) management in atrial fibrillation and acute coronary syndrome (ACS)/percutaneous coronary intervention (PCI) - Clinical practice perspective
  • Speaker : RF Storey (Sheffield,GB), R Lopes (Durham,US), S Halvorsen (Oslo,NO)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Questions and answers

Event : ESC Congress 2019

  • Session : Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)
  • Speaker : M Gilard (Brest Cedex,FR), R Lopes (Durham,US)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Anticoagulation in atrial fibrillation: what the trials tell us and gaps in current knowledge.

Event : ESC Congress 2018

  • Session : Advances in anticoagulation to improve patient care in atrial fibrillation
  • Speaker : R Lopes (Durham,US)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Atrial fibrillation patients who develop acute coronary syndrome: Is there a role for aspirin?

Event : ESC Congress 2018

  • Session : Atrial fibrillation patients who develop acute coronary syndrome: is there a role for aspirin?
  • Speaker : R Lopes (Durham,US), S Windecker (Bern,CH), S Halvorsen (Oslo,NO)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Optimal delivery of care in emerging countries.

Event : Acute Cardiovascular Care 2018

  • Session : Translating scientific evidence into clinical practice
  • Speaker : R Lopes (Durham,US)

Use of apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE

Event : ESC Congress 2013

  • Session : Arrhythmias - Pacing - Resynchronisation
  • Speaker : R Lopes (Durham,US)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are